Prashant Tembhare

Homi Bhabha National Institute — India

Medicine · Health Sciences

23h-index5.6kcitations240works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(69), Acute Lymphoblastic Leukemia research(65), Multiple Myeloma Research and Treatments(54), Chronic Lymphocytic Leukemia Research(50), Lymphoma Diagnosis and Treatment(36)

Publications239 total

Attrition Rates in Multiple Myeloma - A Report from indian Patients at A Tertiary Cancer Center
Indian Journal of Hematology and Blood Transfusion·2025Open Access
Multiple Myeloma in Young Adults—Insights From a Tertiary Care Cancer Centre in India
eJHaem·2025Open Access
Presenting features, treatment patterns and predictors of outcomes in AL amyloidosis at a tertirary care cancer centre
Blood·2025Open Access
Hemodilution assessment for high-sensitivity flow cytometric measurable residual disease evaluation in pediatric B-cell acute lymphoblastic leukemia
Blood·2025Open Access
Baseline characteristics, serological and measurable residual disease responses and outcomes in newly diagnosed multiple myeloma patients not planned for autologous stem cell transplant; Results from a prospective randomised study using MRD guided therapy
Blood·2025Open Access
Treatment free remission (TFR) in chronic myeloid leukemia—results, compliance and patterns of failure from a tertiary care cancer centre in India
Blood Cancer Journal·2025Open Access
Clinical Characteristics and Long Term Outcomes of POEMS Syndrome from a Tertiary Care Cancer Center
Clinical Lymphoma Myeloma & Leukemia·2025
Clinical Profile, Treatment Patterns, Outcomes and Predictors of Survival in AL Amyloidosis: A Retrospective Study from a Tertiary Cancer Center
Clinical Lymphoma Myeloma & Leukemia·2025
Patterns of Use, Outcomes and Tolerance to Daratumumab in Multiple Myeloma: A Single-Centre Retrospective Study
Clinical Lymphoma Myeloma & Leukemia·2025
AML-672: Delineating the Trajectories of Venetoclax-Azacitidine (Ven-Aza) Combination Therapy Resistance in Acute Myeloid Leukemia (AML)
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: AML-672 Delineating the Trajectories of Venetoclax-Azacitidine (Ven-Aza) Combination Therapy Resistance in Acute Myeloid Leukemia (AML)
Clinical Lymphoma Myeloma & Leukemia·2025
Moving Beyond G‐CSF Mobilization—Learning From a 15‐Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma
Cancer Medicine·2025· 4 citedOpen Access
Concurrent ETV6::ABL1 and BCR::ABL1 in a rare case of Chronic Myeloid Leukemia: A paradox of imatinib resistance and indolent clinical course
2025Open Access
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India
Clinical Lymphoma Myeloma & Leukemia·2025
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
Blood Cancer Journal·2025Open Access
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India
The Lancet Regional Health - Southeast Asia·2025· 5 citedOpen Access
Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings
Journal of Clinical Pathology·2025· 1 cited
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India – Knowing the Unknown
Indian Journal of Hematology and Blood Transfusion·2025· 4 citedOpen Access
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
Blood Cancer Journal·2025· 7 citedOpen Access
Fifth edition WHO classification: myeloid neoplasms
Journal of Clinical Pathology·2025· 1 cited
page 1 of 12Next →

Frequent Co-authors

Nikhil Patkar(33), Sumeet Gujral(32), Papagudi Ganesan Subramanian(29), Manju Sengar(20), Gaurav Chatterjee(19), Bhausaheb Bagal(18), Gaurav Narula(17), Hasmukh Jain(16), Nilesh Deshpande(14), Sitaram Ghogale(14), Yajamanam Badrinath(14), Dhanalaxmi Shetty(12), Navin Khattry(12), Shripad Banavali(12), Shruti Chaudhary(11), Swapnali Joshi(10), Constance M. Yuan(9), Maryalice Stetler‐Stevenson(9), Hari Menon(8), Twinkle Khanka(8)